[REVISION HISTORY]
Gender disparities in autoimmune disease diagnosis
Updated 1 time since CLSTR started tracking revisions of this situation.
What changed
2026-10-16 19:02 UTC → 2026-10-16 19:42 UTC ·
added
removed
An international study published in The Lancet eClinicalMedicine, conducted by the University of Cambridge and the University of East Anglia, has identified significant gender disparities in the diagnosis of autoimmune diseases. Research involving over 6,600 patients indicates that women face substantially longer diagnostic delays and higher rates of misdiagnosis than men. While men frequently receive diagnoses within three months of symptom onset, women often wait between one and two years. The study found that women are approximately 46% more likely to receive an incorrect psychiatric diagnosis and 74% more likely to have symptoms attributed to psychosomatic causes. Specific data from the analysis shows that 43% of women reported their symptoms were previously attributed to psychiatric issues, compared to 33% of men. Additionally, 34% of women reported their symptoms were considered psychosomatic, while the figure for men was 22%. These misattributions often occur because autoimmune conditions—such as lupus, rheumatoid arthritis, and thyroid disease—frequently present with vague symptoms like fatigue and pain. Researchers suggest these disparities may result from historical gender biases where physical symptoms like fatigue and pain are dismissed as emotional or psychological issues. Lead researcher Melanie Sloan noted that such misinterpretations can lead to long-lasting consequences for patients' well-being and their trust in medical professionals.
Versions
- 2026-10-16 19:42 UTC Gender disparities in autoimmune disease diagnosis
- 2026-10-16 19:02 UTC Gender disparities in autoimmune disease diagnosis
Only revisions since CLSTR began indexing content versions appear here. Select a version to see what changed compared to the one before it.